Login / Signup

Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review.

Na NiuMeghan M HebertonZhenya TangLeomar Y BallesterPriyardhisini NagarajanJonathan L CurryVictor G PrietoCarlos A Torres-CabalaWoo Cheal Cho
Published in: Journal of cutaneous pathology (2023)
Lymphomatoid papulosis (LyP) with DUSP22-IRF4 rearrangement is a rare, recently described variant of LyP histopathologically characterized by a biphasic growth pattern, with epidermotropic small-to-medium-sized atypical T-cells and dermal large and transformed T-cells diffusely expressing CD30. LyP with DUSP22-IRF4 rearrangement can mimic other cutaneous lymphoproliferative disorders, particularly primary cutaneous anaplastic large cell lymphoma (PCALCL) or transformed mycosis fungoides (MF). Unlike PCALCL or transformed MF, LyP with DUSP22-IRF4 rearrangement shows an indolent clinical behavior, with frequent spontaneous regression of untreated lesions. Thus, it is important to recognize this rare variant of LyP to avoid misclassification, which may potentially lead to unnecessarily aggressive patient management. To our knowledge, only 13 cases of LyP with DUSP22-IRF4 rearrangement have been reported to date in the English literature. Herein, we describe an additional case of LyP with DUSP22-IRF4 rearrangement in a 63-year-old man and provide a comprehensive literature review with regards to the clinical, histopathologic, and molecular features of this novel entity.
Keyphrases
  • dendritic cells
  • systematic review
  • case report
  • healthcare
  • stem cells
  • single cell
  • immune response
  • cell therapy
  • epstein barr virus
  • mesenchymal stem cells
  • bone marrow
  • wild type